Targeting co-stimulatory molecules in autoimmune disease

NM Edner, G Carlesso, JS Rush… - Nature Reviews Drug …, 2020 - nature.com
Therapeutic targeting of immune checkpoints has garnered significant attention in the area
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …

Co-stimulatory and co-inhibitory pathways in autoimmunity

Q Zhang, DAA Vignali - Immunity, 2016 - cell.com
The immune system is guided by a series of checks and balances, a major component of
which is a large array of co-stimulatory and co-inhibitory pathways that modulate the host …

New therapies for treatment of rheumatoid arthritis

JS Smolen, D Aletaha, M Koeller, MH Weisman… - The lancet, 2007 - thelancet.com
Rheumatoid arthritis is characterised by pain, swelling, and destruction of joints, with
resultant disability. Only disease-modifying antirheumatic drugs can interfere with the …

The NOD mouse: a model of immune dysregulation

MS Anderson, JA Bluestone - Annu. Rev. Immunol., 2005 - annualreviews.org
▪ Abstract Autoimmunity is a complex process that likely results from the summation of
multiple defective tolerance mechanisms. The NOD mouse strain is an excellent model of …

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

JM Kremer, R Westhovens, M Leon… - … England Journal of …, 2003 - Mass Medical Soc
Background Effective new therapies are needed for rheumatoid arthritis. Current therapies
target the products of activated macrophages; however, T cells also have an important role …

Vstm3 is a member of the CD28 family and an important modulator of T‐cell function

SD Levin, DW Taft, CS Brandt, C Bucher… - European journal of …, 2011 - Wiley Online Library
Members of the CD28 family play important roles in regulating T‐cell functions and share a
common gene structure profile. We have identified VSTM3 as a protein whose gene …

Tolerance and autoimmunity

T Kamradt, NA Mitchison - New England Journal of Medicine, 2001 - Mass Medical Soc
The immunologic specificity of the antigen receptors of T cells and B cells is the result of
random shuffling of the many genes that form the DNA code for the antigen-binding site of …

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

JR Abrams, MG Lebwohl, CA Guzzo… - The Journal of …, 1999 - Am Soc Clin Investig
Engagement of the B7 family of molecules on antigen-presenting cells with their T cell–
associated ligands, CD28 and CD152 (cytotoxic T lymphocyte–associated antigen-4 [CTLA …

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve‐month results of a phase IIb, double‐blind, randomized, placebo …

JM Kremer, M Dougados, P Emery… - … : Official Journal of …, 2005 - Wiley Online Library
Objective To determine the clinical efficacy, safety, and immunogenicity of abatacept (CTLA‐
4Ig), a selective costimulation modulator, in patients with rheumatoid arthritis (RA) that has …

[PDF][PDF] Evaluation of therapeutic targets in animal models of arthritis

L Bevaart, MJ Vervoordeldonk, PP Tak - Arthritis Rheum, 2010 - academia.edu
Rheumatoid arthritis (RA) is a chronic, systemic, immune-mediated inflammatory disease
associated with decreased life expectancy and quality of life. RA is characterized by chronic …